Diabetes drug and antihistamine could together repair multiple sclerosis damage, trial finds

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...
Multiple Sclerosis News Today

ECTRIMS 2025: Drug combo shows promise for myelin repair in trial

Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...

MS trial results suggest drugs could repair damage

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition.
BioSpace

FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December

The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
KTBS 3

Pharma Payments Might Influence MS Drug Prescriptions, Researchers Argue

Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were ...
MedPage Today on MSN

Novel Drug Shows Hints of Promise for Progressive MS

Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...

FDA Delays Key Sanofi Multiple Sclerosis Drug Decision

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug ...
Zacks Investment Research on MSN

FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing

Sanofi SNY announced that the FDA has extended the target action date for its new drug application (NDA) for tolebrutinib by ...